Exploring 3 High Growth Tech Stocks In The United Kingdom
In This Article:
Amidst the recent downturn in the FTSE 100 and FTSE 250 indices, driven by weak trade data from China and its impact on global markets, investors are closely monitoring high-growth sectors for potential opportunities. In this environment, identifying tech stocks with robust growth prospects and resilience to external economic pressures can be crucial for navigating market volatility.
Top 10 High Growth Tech Companies In The United Kingdom
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Facilities by ADF | 26.24% | 161.47% | ★★★★★☆ |
| Pinewood Technologies Group | 27.24% | 25.48% | ★★★★★☆ |
| Redcentric | 5.32% | 67.90% | ★★★★★☆ |
| YouGov | 7.55% | 56.01% | ★★★★★☆ |
| Windar Photonics | 36.65% | 46.33% | ★★★★★☆ |
| Audioboom Group | 32.11% | 175.02% | ★★★★★☆ |
| Vinanz | 113.60% | 125.86% | ★★★★★☆ |
| Beeks Financial Cloud Group | 22.12% | 36.94% | ★★★★★☆ |
| Faron Pharmaceuticals Oy | 45.35% | 15.15% | ★★★★★☆ |
| Cordel Group | 33.50% | 148.58% | ★★★★★☆ |
Click here to see the full list of 41 stocks from our UK High Growth Tech and AI Stocks screener.
Here's a peek at a few of the choices from the screener.
Craneware
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Craneware plc, along with its subsidiaries, specializes in developing, licensing, and supporting computer software for the healthcare sector in the United States, with a market capitalization of £623.32 million.
Operations: The company generates revenue primarily from its healthcare software segment, which contributed $198.10 million.
Craneware plc, a key player in the healthcare software sector, showcases robust financial and operational growth. With a notable 58.9% earnings increase over the past year outpacing its industry's -9.9% downturn, Craneware is setting benchmarks in financial performance. Recent half-year results further underscore this trend with sales rising to $100.05 million from $91.21 million and net income improving significantly to $7.24 million from $4.06 million previously. The firm also announced a dividend increase to 13.5 pence per share, reflecting confidence in ongoing fiscal health and commitment to shareholder returns amidst an evolving healthcare landscape where technology plays an increasingly critical role.
-
Take a closer look at Craneware's potential here in our health report.
-
Understand Craneware's track record by examining our Past report.
Redcentric
Simply Wall St Growth Rating: ★★★★★☆
Overview: Redcentric plc offers IT managed services to both public and private sectors in the United Kingdom, with a market capitalization of £195.04 million.
Operations: With a revenue of £167.94 million, Redcentric plc focuses on providing IT managed services across the public and private sectors in the UK.